Amylyx Pharmaceuticals, Inc. (NasdaqGS: AMLX)
Health Care · Pharmaceuticals · US
$27.72
-1.49% today · +94.5% 1Y
Amylyx Pharmaceuticals, Inc. (NasdaqGS: AMLX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.53B and employs 136 people.
Over the last twelve months the share price has gained 94.5%, trading between 10.83 and 41.14.
Tweenvest scores Amylyx Pharmaceuticals, Inc. across four factors: quality 46/100, value 91/100. Its strongest factor is value.
AMLX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.53B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.43
- Dividend yield
- —
- Beta (5Y)
- -0.09
- 52-week high
- $41.14
- 52-week low
- $10.83
- Avg volume (3M)
- —
- Shares outstanding
- 125.51M
- Employees
- 136
- Next earnings
- —
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
- ISIN
- US03237H1014
- Founded
- 2013
- Listed since
- Jan 7, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Organon & Co.NYSE: OGN | $3.63B | $13.79 | -0.14% |
| Emcure Pharmaceuticals LimitedNSEI: EMCURE | $3.59B | Rs1,833.50 | -5.71% |
| Simcere Pharmaceutical Group LimitedSEHK: 2096 | $3.56B | HK$10.89 | -4.97% |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSHSE: 600329 | $3.56B | CN¥35.80 | +0.73% |
| Livzon Pharmaceutical Group Inc.SZSE: 000513 | $3.52B | CN¥30.50 | +3.01% |
| China Resources Pharmaceutical Group LimitedSEHK: 3320 | $3.51B | HK$4.38 | +1.98% |
| Santen Pharmaceutical Co., Ltd.TSE: 4536 | $3.42B | ¥1,684.00 | +2.34% |
| Wockhardt LimitedNSEI: WOCKPHARMA | $3.35B | Rs1,996.40 | -4.20% |
Figures last refreshed Oct 11, 2026.